Abstract S26 Table 1

Comparison of U.K. with other European countries on the annual use and impact on greenhouse gas (GHG) emissions of short-acting β2-agonist (SABA) relievers vs total inhaler usage (reliever & preventer)

CountrySABA vs total inhaler use (%)SABA vs total inhaler GHG emissions (%)SABA GHG emissions (tonnes CO2e*)SABA use per capita (,000 doses/10,000 people)SABA GHG emissions per capita (tonnes CO2e/10,000 people)
Italy46.554.8104,50312617
Spain58.969.3195,77131940
France62.572.6334,71538350
Germany54.167.1293,63827636
U.K.70.267.5862,6851034134
  • *CO2 equivalent